To determine whether the RAB3C and dystrophin are related to the clinicopathological parameters of cancer patients, we performed the IHC staining of dystrophin and RAB3C on the colorectal tissue arrays to assess whether their expressions can be considered predictors of a poor prognosis in CRC (Fig. 5A,B). Here, DMD is linked to colorectal carcinoma.